Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Prostaglandins Other Lipid Mediat ; 121(Pt A): 53-62, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26201058

RESUMO

Statins are suggested to possess healing properties due to their antioxidant and antiinflammatory effects in animal ulcer models. In contrary, a clinical report indicated the formation of gastric ulcer by the use of atorvastatin. In this study, we aimed to investigate the effects of atorvastatin (0.5, 5 and 50mg/kg, p.o.) after single (acute) and multiple (subchronic, 5 days) applications on indomethacin-induced gastric ulcer in rats. In both acute and subchronic models high dose atorvastatin (50mg/kg), unlike to lower doses (0,5 and 5mg/kg), significantly aggravated ulcer lesions induced by indomethacin (30 mg/kg) although, a direct ulcerogenic influence was lacking. Proulcerogenic effect of atorvastatin are likely to be associated with decreased mucosal defense mechanisms (GSH and PGE2), and increased neutrophil infiltration and proinflammatory factors (TNF-a and iNOS) possibly via independently from mevalonate pathway. Thus, atorvastatin therapy should be monitorized in patients for an increased risk of gastric ulcer particularly when used concomitantly with NSAIDs.


Assuntos
Atorvastatina/farmacologia , Dinoprostona/metabolismo , Indometacina/farmacologia , Neutrófilos/efeitos dos fármacos , Óxido Nítrico Sintase Tipo II/metabolismo , Úlcera Gástrica/induzido quimicamente , Fator de Necrose Tumoral alfa/metabolismo , Amidinas/farmacologia , Animais , Benzilaminas/farmacologia , Sinergismo Farmacológico , Feminino , Masculino , Ácido Mevalônico/farmacologia , Infiltração de Neutrófilos/efeitos dos fármacos , Neutrófilos/imunologia , Ratos , Úlcera Gástrica/imunologia , Úlcera Gástrica/metabolismo
2.
Phytother Res ; 21(11): 1070-5, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17685385

RESUMO

In this study, the prophylactic effect of the main lectin present in Aloe vera leaf pulp extract (Aloctin I) was assayed against Ehrlich ascites tumours in mice. The lectin administered prophylactically before tumour implantation regressed tumour size, however, this activity was less potent than that of the A. vera leaf pulp extract previously shown in our laboratory. Accordingly, serum sialic acid and tumour necrosis factor alpha (TNFalpha) levels, chosen as tumour markers, were decreased significantly by the prophylactic administration of the lectin. The increase in spleen and thymus weights in the group given only Aloctin I, could be explained by the immunomodulatory and mitogenic effects of lectins. These findings, along with lymphoid hyperplasia observed in spleen and thymus, suggest that the tumour preventive effect of Aloctin I could be due to its immunomodulatory activity.


Assuntos
Aloe/química , Carcinoma de Ehrlich/prevenção & controle , Folhas de Planta/química , Lectinas de Plantas/uso terapêutico , Animais , Carcinoma de Ehrlich/sangue , Carcinoma de Ehrlich/patologia , Contagem de Leucócitos , Masculino , Camundongos , Ácido N-Acetilneuramínico/sangue , Tamanho do Órgão/efeitos dos fármacos , Lectinas de Plantas/isolamento & purificação , Lectinas de Plantas/farmacologia , Baço/efeitos dos fármacos , Baço/patologia , Timo/efeitos dos fármacos , Timo/patologia , Fator de Necrose Tumoral alfa/sangue
3.
Pancreatology ; 5(4-5): 345-53, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15980663

RESUMO

BACKGROUND AND AIMS: Secondary bacterial infections and free radical injury have been known to play an important role in the pathogenesis and clinical outcome of acute pancreatitis. Despite the therapy models developed in recent years, the mortality rate is still reported to be higher than expected. The objective of this study therefore was to investigate the effectiveness of ciprofloxacin and metronidazole combination and curcumin together in the treatment of acute pancreatitis. METHODS: Acute pancreatitis was induced in rats by sodium taurocholate (n = 60). Starting 6 h after the induction of acute pancreatitis, groups I and II were injected 200 mg/kg ciprofloxacin and 500 mg/kg metronidazole intraperitoneally every 12 h for 6 days. Groups II and III received 100 mg/kg curcumin since day 20 prior to the initiation of acute pancreatitis. On day 6, animals of all groups were killed. Blood and tissue samples were taken for biochemical, pathologic and bacteriologic examination. RESULTS: No statistical difference in the treatment groups versus the non-treatment group has been detected in the pancreatic tissue on the basis of histopathological scoring results. Prevalences of bacterial translocation were significantly lower in the treatment groups (groups I-III) than in the non-treatment group (group IV) (p < 0.001, p < 0.001, p < 0.05, respectively). Serum amylase, lipase, malon dialdehyde and nitric oxide (except for nitric oxide level in group I), levels of groups I, II and III were significantly lower than those of group IV (p < 0.05). CONCLUSIONS: The administration of ciprofloxacin and metronidazole in combination and curcumin in acute pancreatitis failed to provide a preventive effect on the occurrence of tissue injury, whereas free radical injury and prevalence of bacterial translocation were reduced significantly.


Assuntos
Anti-Infecciosos/uso terapêutico , Ciprofloxacina/uso terapêutico , Curcumina/uso terapêutico , Inibidores Enzimáticos/uso terapêutico , Metronidazol/uso terapêutico , Pancreatite Necrosante Aguda/tratamento farmacológico , Pancreatite Necrosante Aguda/patologia , Animais , Anti-Infecciosos/farmacologia , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Translocação Bacteriana/efeitos dos fármacos , Ciprofloxacina/farmacologia , Curcumina/farmacologia , Modelos Animais de Doenças , Quimioterapia Combinada , Inibidores Enzimáticos/farmacologia , Masculino , Metronidazol/farmacologia , Pancreatite Necrosante Aguda/induzido quimicamente , Ratos , Ratos Wistar , Ácido Taurocólico , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA